ALIVUS LIFE SCIENCES
Back to Balance Sheet
|
ALIVUS LIFE SCIENCES Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹4.82 Cr | ₹4.82 Cr | ₹4.82 Cr | ₹2.22 Cr | ₹2.22 Cr |
What is the latest Contingent Liabilities ratio of ALIVUS LIFE SCIENCES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹4.82 Cr |
| Mar2025 | ₹4.82 Cr |
| Mar2024 | ₹4.82 Cr |
| Mar2023 | ₹2.22 Cr |
| Mar2022 | ₹2.22 Cr |
How is Contingent Liabilities of ALIVUS LIFE SCIENCES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹4.82 Cr | 0.00 | |
| Mar2025 | ₹4.82 Cr | 0.00 | |
| Mar2024 | ₹4.82 Cr | 117.33 | |
| Mar2023 | ₹2.22 Cr | 0.00 | |
| Mar2022 | ₹2.22 Cr | - | |
Compare Contingent Liabilities of peers of ALIVUS LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALIVUS LIFE SCIENCES | ₹17,178.5 Cr | 2.7% | 23.4% | 50.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹450,211.0 Cr | -3% | -4.1% | 16.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹228,303.0 Cr | 0.6% | 17.5% | 41.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.7% | -0.6% | 35.5% | Stock Analytics | |
| CIPLA | ₹115,672.0 Cr | -2% | -0.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,533.5 Cr | -1.5% | -3.5% | -2.2% | Stock Analytics | |
ALIVUS LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALIVUS LIFE SCIENCES | 2.7% |
23.4% |
50.7% |
| SENSEX | -1.2% |
-1.2% |
-3.3% |
You may also like the below Video Courses